Nicolai Tangen
AKO Capital
AKO Capital Portfolio 13F
Nicolai Tangen Holdings Activity
- Portfolio value:
- $10.27B≈ (+$622M≈)
- Previous value:
- $9.65B≈
- # of changes:
- 25
- New positions:
- 0
- Reported for:
- 31 Dec 2021 (Q4)
- Latest filing date:
- 04 Feb 2022
AKO Capital has disclosed a total of 25 changes to the portfolio in the (2021 Q4) SEC report(s): increased the number of shares of 11, decreased the number of shares of 13 and completely sold out 1 position(s).
What stocks did Nicolai Tangen buy in 2021 Q4?
During 2021 Q4 Nicolai Tangen has bought 11 securities out of which top 5 purchases (by % change to portfolio) were (BKNG) Booking Holdings Inc (added shares +36.53%), (ACN) Accenture plc (added shares +10.13%), (TMO) Thermo Fisher Scientific Inc (added shares +7.65%), (ICE) Intercontinental Exchange Inc (added shares +35.05%) and (EFX) Equifax Inc (added shares +6.46%).
What did Nicolai Tangen invest in during 2021 Q4?
In the 2021 Q4 report(s) the following changes have been made to the top investments: (BKNG) Booking Holdings Inc (added shares +36.53%), (ACN) Accenture plc (added shares +10.13%), (LIN) Linde plc Ordinary Shares (reduced shares -24.63%), (TMO) Thermo Fisher Scientific Inc (added shares +7.65%) and (ICE) Intercontinental Exchange Inc (added shares +35.05%).
25 results
| History | Ticker | Name |
% or activity |
Shares change |
Shares held after* |
% change to portfolio |
Reported price* |
% difference current price* |
% of portfolio |
Held since* | Held for* |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Booking Holdings Inc
|
+36.53%
|
+3,501,750
|
13,087,250
|
+3.27%
|
$95.97
|
+100.80%($192.71)
|
12.23%
|
2020 Q1
|
≈ 2.00 years
|
|
|
|
Intercontinental Exchange Inc
|
+35.05%
|
+993,677
|
3,828,454
|
+1.32%
|
$136.77
|
+8.23%($148.03)
|
5.10%
|
2020 Q3
|
≈ 1.50 years
|
|
|
|
Procter & Gamble Company
|
+28.61%
|
+557,113
|
2,504,218
|
+0.89%
|
$163.58
|
-9.81%($147.53)
|
3.99%
|
2018 Q4
|
≈ 3.25 years
|
|
|
|
Diageo PLC ADR
|
+21.40%
|
+306,394
|
1,738,289
|
+0.66%
|
$220.14
|
-60.03%($88.00)
|
3.73%
|
2021 Q1
|
≈ 1.00 year
|
|
|
|
ANSYS Inc
|
+15.58%
|
+46,188
|
342,737
|
+0.18%
|
$401.12
|
|
1.34%
|
2016 Q4
|
≈ 5.25 years
|
|
|
|
Accenture plc
|
+10.13%
|
+227,692
|
2,474,492
|
+0.92%
|
$414.55
|
-59.56%($167.66)
|
9.99%
|
2021 Q3
|
≈ 0.50 years
|
|
|
|
Thermo Fisher Scientific Inc
|
+7.65%
|
+87,438
|
1,229,899
|
+0.57%
|
$667.24
|
-14.86%($568.09)
|
7.99%
|
2020 Q3
|
≈ 1.50 years
|
|
|
|
Equifax Inc
|
+6.46%
|
+99,709
|
1,642,337
|
+0.28%
|
$292.79
|
-40.08%($175.44)
|
4.68%
|
2021 Q1
|
≈ 1.00 year
|
|
|
|
Estee Lauder Companies Inc
|
+6.24%
|
+75,039
|
1,278,114
|
+0.27%
|
$370.20
|
-76.66%($86.40)
|
4.61%
|
2016 Q4
|
≈ 5.25 years
|
|
|
|
Fair Isaac Corp
|
+4.10%
|
+10,005
|
254,262
|
+0.04%
|
$433.67
|
+142.04%($1,049.66)
|
1.07%
|
2016 Q4
|
≈ 5.25 years
|
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
* Current price: this can be a delayed price and may not reflect the real-time market value, however it is too close.
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* Held since / Held for: calculated since the latest "new buy" position. If the security was previously exited and re-entered, only the most recent holding period is counted.